GENSCRIPT BIO (01548) extended its gains, rising over 5% and trading 3.95% higher at HK$19.49 as of the latest update, with turnover reaching HK$287 million.
The company plans to hold a board meeting on August 15 to approve its interim results. According to a previous announcement, in the second quarter, Legend Biotech's CARVYKTI sales reached US$657 million, a year-on-year increase of 49.4% and a sequential rise of 10%. First-half sales totaled US$1.254 billion, up 55.1% from the same period last year.